Jiuyuan Liu , Shihui Zhao , Shanling Liu , Yanbing Guo , Shuang Zhang , Di Bao , Yiming Wei , Jiangting Niu , Shushuai Yi , Hongze Shao , Hao Dong , Kai Wang , Guixue Hu
{"title":"Activation of the TLR2/NF-κB signaling axis by capsid proteinVP1 of feline calicivirus promotes IL-1β expression in vitro","authors":"Jiuyuan Liu , Shihui Zhao , Shanling Liu , Yanbing Guo , Shuang Zhang , Di Bao , Yiming Wei , Jiangting Niu , Shushuai Yi , Hongze Shao , Hao Dong , Kai Wang , Guixue Hu","doi":"10.1016/j.vetmic.2025.110693","DOIUrl":null,"url":null,"abstract":"<div><div>Feline calicivirus (FCV) induces systemic inflammation in felines, posing a serious threat to feline health worldwide. Severe cases may lead to chronic stomatitis and other inflammatory conditions. However, the precise mechanisms underlying FCV-induced inflammation remain unclear. To investigate the involvement of toll-like receptors (TLRs), in vitro experiments assessed changes in TLR gene expression following FCV infection. FCV infection significantly upregulated TLR2 and TLR7 transcription, as well as expression of the NLRP3 gene. Functional assays revealed that inhibition or silencing of TLR2 markedly reduced FCV-induced transcription and secretion of proinflammatory cytokines IL-1β, IL-6, and TNF-α. Conversely, TLR2 overexpression enhanced IL-1β transcription and secretion, further implicating TLR2 in FCV-mediated inflammatory signaling. Mechanistically, FCV infection increased the expression of TLR2 and MyD88, promoted IκBα phosphorylation and degradation, and facilitated NF-κB (p65) phosphorylation and nuclear translocation. Disruption of TLR2 or MyD88 abrogated these events, thereby blocking NF-κB activation and downstream IL-1β expression. Inhibition of any component within the TLR2/MyD88/NF-κB axis—including NF-κB or IκBα—similarly suppressed IL-1β transcription, expression, and secretion, establishing the central role of this pathway in FCV-induced inflammation. Further experiments demonstrated that FCV virus-like particles (VLPs) can induce IL-1β gene transcription through the TLR2/MyD88/NF-κB axis but are insufficient to trigger IL-1β secretion. Dual-luciferase assays confirmed that FCV VP1 alone is capable of activating IL-1β gene transcription via this pathway and directly interacts with TLR2. Collectively, these findings demonstrate that FCV VP1 binds to TLR2, initiates IκBα phosphorylation through MyD88, promotes nuclear translocation of NF-κB (p65), and activates the NF-κB signaling cascade. This cascade primes the inflammasome by inducing transcription of NLRP3, Caspase-1, and IL-1β, as well as expression of the pro-IL-1β precursor, thereby initiating the first signal required for NLRP3 inflammasome activation in FCV-infected cells.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"309 ","pages":"Article 110693"},"PeriodicalIF":2.7000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525003281","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Feline calicivirus (FCV) induces systemic inflammation in felines, posing a serious threat to feline health worldwide. Severe cases may lead to chronic stomatitis and other inflammatory conditions. However, the precise mechanisms underlying FCV-induced inflammation remain unclear. To investigate the involvement of toll-like receptors (TLRs), in vitro experiments assessed changes in TLR gene expression following FCV infection. FCV infection significantly upregulated TLR2 and TLR7 transcription, as well as expression of the NLRP3 gene. Functional assays revealed that inhibition or silencing of TLR2 markedly reduced FCV-induced transcription and secretion of proinflammatory cytokines IL-1β, IL-6, and TNF-α. Conversely, TLR2 overexpression enhanced IL-1β transcription and secretion, further implicating TLR2 in FCV-mediated inflammatory signaling. Mechanistically, FCV infection increased the expression of TLR2 and MyD88, promoted IκBα phosphorylation and degradation, and facilitated NF-κB (p65) phosphorylation and nuclear translocation. Disruption of TLR2 or MyD88 abrogated these events, thereby blocking NF-κB activation and downstream IL-1β expression. Inhibition of any component within the TLR2/MyD88/NF-κB axis—including NF-κB or IκBα—similarly suppressed IL-1β transcription, expression, and secretion, establishing the central role of this pathway in FCV-induced inflammation. Further experiments demonstrated that FCV virus-like particles (VLPs) can induce IL-1β gene transcription through the TLR2/MyD88/NF-κB axis but are insufficient to trigger IL-1β secretion. Dual-luciferase assays confirmed that FCV VP1 alone is capable of activating IL-1β gene transcription via this pathway and directly interacts with TLR2. Collectively, these findings demonstrate that FCV VP1 binds to TLR2, initiates IκBα phosphorylation through MyD88, promotes nuclear translocation of NF-κB (p65), and activates the NF-κB signaling cascade. This cascade primes the inflammasome by inducing transcription of NLRP3, Caspase-1, and IL-1β, as well as expression of the pro-IL-1β precursor, thereby initiating the first signal required for NLRP3 inflammasome activation in FCV-infected cells.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.